The global Bioprocessing Systems market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Manufacturing biologics is a complicated process and thus generally are outsourced by the manufacturers. Bioprocessing is the manufacturing process which helps in producing bio-based products such as vegetable oils, and fatty acids. The major applications of bioprocess industry are vaccines, tissue engineering, biosensors, and biopharmaceuticals. Bioprocessing also is known as biopharmaceutical manufacturing is a bioprocess used for the production of therapeutic cells.
The global bioprocessing systems market witnessed significant growth owing to increasing demand for bio-based products. The heavy demand for such systems by the industries such as food, pharmaceuticals, neutraceuticals, chemicals and polymers coupled with automation in the industrial process minimizing human errors have propelled the growth of global bioprocessing market. Moreover, the factors such as rising demand for biopharmaceutical production, increasing symptoms of chronic diseases, low manufacturing costs as compared to the artificial source of materials and improvisation of infrastructure in life science research has triggered the global bioprocessing systems during the forecast period 2017-2027. Growing demand for the single 鈥搖se systems of the bioprocessing systems is expected to gain traction during the forecast period which is supposed to augment the global bioprocessing system market.
Report includes an overview of the development of the Bioprocessing Systems industry chain, the market status of Vaccine Development (Upstream, Downstream), Cell Therapy and Plant Cell Cultivation (Upstream, Downstream), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Bioprocessing Systems.
Regionally, the report analyzes the Bioprocessing Systems markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Bioprocessing Systems market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Bioprocessing Systems market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Bioprocessing Systems industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Upstream, Downstream).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Bioprocessing Systems market.
Regional Analysis: The report involves examining the Bioprocessing Systems market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Bioprocessing Systems market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Bioprocessing Systems:
Company Analysis: Report covers individual Bioprocessing Systems players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Bioprocessing Systems This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Vaccine Development, Cell Therapy and Plant Cell Cultivation).
Technology Analysis: Report covers specific technologies relevant to Bioprocessing Systems. It assesses the current state, advancements, and potential future developments in Bioprocessing Systems areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Bioprocessing Systems market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Bioprocessing Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Upstream
Downstream
Single Use
Integrated
麻豆原创 segment by Application
Vaccine Development
Cell Therapy and Plant Cell Cultivation
Filters
Tissue Engineering
Biosensors
Bioreactors and Mixers
Plasma Fractionation
Chromatography
Bio-therapeutic Molecule Production
麻豆原创 segment by players, this report covers
Lonza
Pall Corporation
GE Healthcare
Nordson MEDICAL's
Thermo Fisher Scientific
EMD Millipore Corporation
PBS Biotech
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Bioprocessing Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bioprocessing Systems, with revenue, gross margin and global market share of Bioprocessing Systems from 2019 to 2024.
Chapter 3, the Bioprocessing Systems competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Bioprocessing Systems market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bioprocessing Systems.
Chapter 13, to describe Bioprocessing Systems research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Bioprocessing Systems
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Bioprocessing Systems by Type
1.3.1 Overview: Global Bioprocessing Systems 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Bioprocessing Systems Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Upstream
1.3.4 Downstream
1.3.5 Single Use
1.3.6 Integrated
1.4 Global Bioprocessing Systems 麻豆原创 by Application
1.4.1 Overview: Global Bioprocessing Systems 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Vaccine Development
1.4.3 Cell Therapy and Plant Cell Cultivation
1.4.4 Filters
1.4.5 Tissue Engineering
1.4.6 Biosensors
1.4.7 Bioreactors and Mixers
1.4.8 Plasma Fractionation
1.4.9 Chromatography
1.4.10 Bio-therapeutic Molecule Production
1.5 Global Bioprocessing Systems 麻豆原创 Size & Forecast
1.6 Global Bioprocessing Systems 麻豆原创 Size and Forecast by Region
1.6.1 Global Bioprocessing Systems 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Bioprocessing Systems 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Bioprocessing Systems 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Bioprocessing Systems 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Bioprocessing Systems 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Bioprocessing Systems 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Bioprocessing Systems 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Bioprocessing Systems Product and Solutions
2.1.4 Lonza Bioprocessing Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Pall Corporation
2.2.1 Pall Corporation Details
2.2.2 Pall Corporation Major Business
2.2.3 Pall Corporation Bioprocessing Systems Product and Solutions
2.2.4 Pall Corporation Bioprocessing Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Pall Corporation Recent Developments and Future Plans
2.3 GE Healthcare
2.3.1 GE Healthcare Details
2.3.2 GE Healthcare Major Business
2.3.3 GE Healthcare Bioprocessing Systems Product and Solutions
2.3.4 GE Healthcare Bioprocessing Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 GE Healthcare Recent Developments and Future Plans
2.4 Nordson MEDICAL's
2.4.1 Nordson MEDICAL's Details
2.4.2 Nordson MEDICAL's Major Business
2.4.3 Nordson MEDICAL's Bioprocessing Systems Product and Solutions
2.4.4 Nordson MEDICAL's Bioprocessing Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Nordson MEDICAL's Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Bioprocessing Systems Product and Solutions
2.5.4 Thermo Fisher Scientific Bioprocessing Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 EMD Millipore Corporation
2.6.1 EMD Millipore Corporation Details
2.6.2 EMD Millipore Corporation Major Business
2.6.3 EMD Millipore Corporation Bioprocessing Systems Product and Solutions
2.6.4 EMD Millipore Corporation Bioprocessing Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 EMD Millipore Corporation Recent Developments and Future Plans
2.7 PBS Biotech
2.7.1 PBS Biotech Details
2.7.2 PBS Biotech Major Business
2.7.3 PBS Biotech Bioprocessing Systems Product and Solutions
2.7.4 PBS Biotech Bioprocessing Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 PBS Biotech Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Bioprocessing Systems Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Bioprocessing Systems by Company Revenue
3.2.2 Top 3 Bioprocessing Systems Players 麻豆原创 Share in 2023
3.2.3 Top 6 Bioprocessing Systems Players 麻豆原创 Share in 2023
3.3 Bioprocessing Systems 麻豆原创: Overall Company Footprint Analysis
3.3.1 Bioprocessing Systems 麻豆原创: Region Footprint
3.3.2 Bioprocessing Systems 麻豆原创: Company Product Type Footprint
3.3.3 Bioprocessing Systems 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Bioprocessing Systems Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Bioprocessing Systems 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Bioprocessing Systems Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Bioprocessing Systems 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Bioprocessing Systems Consumption Value by Type (2019-2030)
6.2 North America Bioprocessing Systems Consumption Value by Application (2019-2030)
6.3 North America Bioprocessing Systems 麻豆原创 Size by Country
6.3.1 North America Bioprocessing Systems Consumption Value by Country (2019-2030)
6.3.2 United States Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Bioprocessing Systems Consumption Value by Type (2019-2030)
7.2 Europe Bioprocessing Systems Consumption Value by Application (2019-2030)
7.3 Europe Bioprocessing Systems 麻豆原创 Size by Country
7.3.1 Europe Bioprocessing Systems Consumption Value by Country (2019-2030)
7.3.2 Germany Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Bioprocessing Systems Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Bioprocessing Systems Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Bioprocessing Systems 麻豆原创 Size by Region
8.3.1 Asia-Pacific Bioprocessing Systems Consumption Value by Region (2019-2030)
8.3.2 China Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Bioprocessing Systems Consumption Value by Type (2019-2030)
9.2 South America Bioprocessing Systems Consumption Value by Application (2019-2030)
9.3 South America Bioprocessing Systems 麻豆原创 Size by Country
9.3.1 South America Bioprocessing Systems Consumption Value by Country (2019-2030)
9.3.2 Brazil Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Bioprocessing Systems Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Bioprocessing Systems Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Bioprocessing Systems 麻豆原创 Size by Country
10.3.1 Middle East & Africa Bioprocessing Systems Consumption Value by Country (2019-2030)
10.3.2 Turkey Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Bioprocessing Systems 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Bioprocessing Systems 麻豆原创 Drivers
11.2 Bioprocessing Systems 麻豆原创 Restraints
11.3 Bioprocessing Systems Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Bioprocessing Systems Industry Chain
12.2 Bioprocessing Systems Upstream Analysis
12.3 Bioprocessing Systems Midstream Analysis
12.4 Bioprocessing Systems Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Lonza
Pall Corporation
GE Healthcare
Nordson MEDICAL's
Thermo Fisher Scientific
EMD Millipore Corporation
PBS Biotech
听
听
*If Applicable.